161 related articles for article (PubMed ID: 26854163)
1. Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT.
Kairemo K; Joensuu T
Diagnostics (Basel); 2015 Oct; 5(4):413-27. PubMed ID: 26854163
[TBL] [Abstract][Full Text] [Related]
2. Uptake of Radium-223 Dichloride and Early [
Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen flare induced by
Castello A; Macapinlac HA; Lopci E; Santos EB
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2256-2263. PubMed ID: 29785515
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting
Yoon J; Ballas L; Desai B; Jadvar H
World J Nucl Med; 2017; 16(3):229-236. PubMed ID: 28670183
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival.
Etchebehere EC; Araujo JC; Fox PS; Swanston NM; Macapinlac HA; Rohren EM
J Nucl Med; 2015 Aug; 56(8):1177-84. PubMed ID: 26069307
[TBL] [Abstract][Full Text] [Related]
7.
Kairemo K; Roszik J; Anderson P; Ravizzini G; Rao A; Macapinlac HA; Subbiah V
Curr Probl Cancer; 2021 Oct; 45(5):100797. PubMed ID: 34706830
[TBL] [Abstract][Full Text] [Related]
8. A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis.
Kairemo K; Kappadath SC; Joensuu T; Macapinlac HA
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33374148
[TBL] [Abstract][Full Text] [Related]
9. A comparison of prostate cancer bone metastases on
Harmon SA; Mena E; Shih JH; Adler S; McKinney Y; Bergvall E; Mehralivand S; Sowalsky AG; Couvillon A; Madan RA; Gulley JL; Eary J; Mease RC; Pomper MG; Dahut WL; Turkbey B; Lindenberg L; Choyke PL
Oncotarget; 2018 Dec; 9(102):37676-37688. PubMed ID: 30701023
[TBL] [Abstract][Full Text] [Related]
10. Radium-223 dichloride therapy in breast cancer with osseous metastases.
Takalkar A; Paryani B; Adams S; Subbiah V
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26581701
[TBL] [Abstract][Full Text] [Related]
11. Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT.
Lee J; Sato MM; Coel MN; Lee KH; Kwee SA
J Nucl Med; 2016 Jul; 57(7):1058-64. PubMed ID: 26912444
[TBL] [Abstract][Full Text] [Related]
12. Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer.
Miyazaki KS; Kuang Y; Kwee SA
Nucl Med Mol Imaging; 2015 Jun; 49(2):160-4. PubMed ID: 26082811
[TBL] [Abstract][Full Text] [Related]
13. Exploratory study of
Akintayo AA; Bilen MA; Abiodun-Ojo OA; Kucuk O; Carthon B; Chen Z; Jani AB; Parent EE; Schuster DM
Am J Nucl Med Mol Imaging; 2021; 11(3):218-229. PubMed ID: 34235000
[TBL] [Abstract][Full Text] [Related]
14. Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience.
Kairemo K; Milton DR; Etchebehere E; Rohren EM; Macapinlac HA
Curr Radiopharm; 2018; 11(2):147-152. PubMed ID: 29956640
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics.
Kairemo K; Joensuu T; Rasulova N; Kiljunen T; Kangasmäki A
Diagnostics (Basel); 2015 Jul; 5(3):358-68. PubMed ID: 26854158
[TBL] [Abstract][Full Text] [Related]
16. Treatment Response Assessment of Skeletal Metastases in Prostate Cancer with
Velez EM; Desai B; Jadvar H
Nucl Med Mol Imaging; 2019 Aug; 53(4):247-252. PubMed ID: 31456857
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.
Matsubara N; Nagamori S; Wakumoto Y; Uemura H; Kimura G; Yokomizo A; Kikukawa H; Mizokami A; Kosaka T; Masumori N; Kawasaki Y; Yonese J; Nasu Y; Fukasawa S; Sugiyama T; Kinuya S; Hosono M; Yamaguchi I; Tsutsui H; Uemura H
Int J Clin Oncol; 2018 Feb; 23(1):173-180. PubMed ID: 28770408
[TBL] [Abstract][Full Text] [Related]
18. Unusual Soft Tissue Uptake of F-18 Sodium Fluoride in Three Patients Undergoing F-18 NaF PET/CT Bone Scans for Prostate Cancer.
Hawkins AS; Howard BA
Nucl Med Mol Imaging; 2017 Sep; 51(3):274-276. PubMed ID: 28878857
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Assessment of Early [
Harmon SA; Perk T; Lin C; Eickhoff J; Choyke PL; Dahut WL; Apolo AB; Humm JL; Larson SM; Morris MJ; Liu G; Jeraj R
J Clin Oncol; 2017 Aug; 35(24):2829-2837. PubMed ID: 28654366
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients.
Muzahir S; Jeraj R; Liu G; Hall LT; Rio AM; Perk T; Jaskowiak C; Perlman SB
Am J Nucl Med Mol Imaging; 2015; 5(2):162-8. PubMed ID: 25973337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
